Learn / LEGN
NASDAQ: LEGN
Legend Biotech (LEGN) stock, explained like you're 5
Legend Biotech trades on the Nasdaq under the ticker LEGN. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.6 billion dollars.
- Ticker
- LEGN
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 3.6 billion dollars
Is Legend Biotech a small, medium or large cap company?
No. Legend Biotech is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.6 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Legend Biotech makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves LEGN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Legend Holdings (SEHK:3396) Stock Looks Reasonable After A 169% Run (Yahoo Finance)
- Legend Biotech (NasdaqGS:LEGN) Stock Forecast & Analyst Predictions (Simply Wall Street)
- LEGN’s New CEO From Novartis Paves Way For Buyout Speculation (Stocktwits)
- FDA clears a study application for a therapy designed to make immune cells inside the body (Stock Titan)
- H.C. Wainwright reiterates Legend Biotech stock rating on strong Carvykti sales (Investing.com)
Follow LEGN in your daily brief
Each trading day at 5 PM ET we post what happened to Legend Biotech and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow LEGN
Questions about Legend Biotech stock
What does Legend Biotech do?
Legend Biotech trades on the Nasdaq under the ticker LEGN. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.6 billion dollars.
What is the ticker symbol for Legend Biotech?
Legend Biotech trades under the ticker LEGN on the Nasdaq.
What is Legend Biotech's market cap?
Legend Biotech is a mid cap stock with a market cap of about 3.6 billion dollars.
How does Legend Biotech make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves LEGN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow LEGN stock every day?
Add LEGN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.